Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable ...

The fear of cancer stems from the dread that it can recur at any time, even after treatment. A South Korean research team has ...

KAIST Professor Jung Kyoon Choi, Dr. Jeong Yeon Kim, and Dr. Jin Hyeon An >Neoantigens are unique markers that distinguish only cancer ...

Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable to perform their roles properly due to suppression by the tumor.

Genmab will stop development of its experimental antibody therapy to treat cancer that was in late-stage trials, the Danish ...

Denmark's Genmab has decided not to continue the development of a drug for cancer, acasunlimab, which had reached phase 3 testing, after a review of its medicines pipeline. The decision to end the ...

A new study reveals how a single cancer protein may simultaneously drive tumor survival and metabolic control, uncovering a ...

A Swedish startup aims to dominate stem cell production while nanotechnology is helping to transform cancer care. What does ...

One of the biggest risk factors for developing liver cancer is a high-fat diet. A new study from MIT reveals how a fatty diet ...

Researchers at the Francis Crick Institute and AlveoliX have developed the first human 'lung-on-chip' model using stem cells ...